Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:scientist
chemist |
| gptkbp:almaMater |
gptkb:Rutgers_University
gptkb:State_University_of_New_York_at_Stony_Brook |
| gptkbp:awardReceived |
gptkb:David_Barry_DART_Achievement_Award
gptkb:American_Chemical_Society_Heroes_of_Chemistry_Award |
| gptkbp:citizenship |
gptkb:United_States
|
| gptkbp:employer |
gptkb:Merck_&_Co.
|
| gptkbp:field |
gptkb:pharmacy
biochemistry |
| gptkbp:gender |
female
|
| https://www.w3.org/2000/01/rdf-schema#label |
Daria Hazuda
|
| gptkbp:knownFor |
HIV integrase inhibitor research
antiviral drug development |
| gptkbp:nationality |
gptkb:American
|
| gptkbp:notableWork |
development of raltegravir
|
| gptkbp:occupation |
chemist
|
| gptkbp:positionHeld |
Vice President of Infectious Diseases Discovery at Merck & Co.
|
| gptkbp:researchInterest |
gptkb:HIV/AIDS
antiviral therapies |
| gptkbp:bfsParent |
gptkb:Hillsborough,_New_Jersey
|
| gptkbp:bfsLayer |
6
|